There are differences in tissue healing profiles and types of wound closure devices used in health care industry. Wound closure devices include specially designed sutures, staples and mechanical apparatus that aid in closing wounds by manipulating edges of the wound tissue closer together. Wound closure devices vary in design and may require tension or pressure adjustment to absorb into the skin, depending on the function and manufacture. The wound closure devices may be indicated for use on chronic, traumatic and surgical wounds and skin grafts and flaps. The ideal wound closure device and technique would be easy to perform consistently, quick to perform, be able to be performed in all clinical circumstances, painless, without the need to remove the device, have excellent cosmetic results and be cost effective.
The global wound closure devices market report provides market size estimates (Revenue US$ million – 2014 to 2021) for key market segments based on the type of device used (adhesives and tissue sealants made up of albumin, glutaraldehyde, collagen, cyanoacrylate, fibrin and polymer; hemostats; surgical staples; sutures, and wound closure strips , etc.), and forecasts growth trends (CAGR% – 2017 to 2021).
The global wound closure devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global wound closure devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global wound closure devices market and included in this report are 3M Health Care, ArthroCare Corporation, B. Braun Melsungen AG, Biomet, Inc., Covidien plc., Derma Sciences, Inc., Ethicon, Inc., Kinetic Concepts, Inc., Medline Industries, Inc., and Smith & Nephew plc.